Filter
535
Filtered Results: 535
Text search:
Clinical
characterization
Featured
Recommendations
57
New Publications
88
Language
Document type
No document type
182
Guidelines
129
Studies & Reports
123
Manuals
40
Fact sheets
25
Strategic & Response Plan
24
Situation Updates
8
Training Material
3
Resource Platforms
1
Countries / Regions
Global
23
India
21
Latin America and the Carribbean
20
Africa
17
Brazil
12
Kenya
9
Nigeria
9
Western and Central Europe
9
South Africa
8
Russia
8
Colombia
7
Middle East and North Africa
7
Germany
6
West and Central Africa
6
Uganda
6
Namibia
6
Liberia
6
Sierra Leone
5
Venezuela
5
East and Southern Africa
5
Zambia
5
Western Pacific Region
4
Eastern Europe and Central Asia
4
Ghana
3
Rwanda
3
Syria
3
Zimbabwe
3
Philippines
3
Mozambique
3
USA
3
Tanzania
3
Angola
3
Tajikistan
2
Chile
2
Cameroon
2
Burkina Faso
2
Peru
2
Malawi
2
Guinea
2
Congo, Democratic Republic of
2
South–East Asia Region
2
France
2
Bolivia
2
Argentina
2
Bangladesh
2
Eastern Europe
2
Yemen
2
Pakistan
2
Nepal
1
Ukraine
1
Lesotho
1
Turkey
1
Benin
1
Senegal
1
Afghanistan
1
Haiti
1
Cambodia
1
Asia
1
Guinea-Bissau
1
Jordan
1
Portugal
1
Southern Africa
1
Vietnam
1
Sudan
1
Ethiopia
1
South Sudan
1
Indonesia
1
Ecuador
1
Myanmar / Burma
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
146
Clinical Guidelines
60
Public Health
27
Pharmacy & Technologies
20
Key Resources
11
Women & Child Health
9
Capacity Building
4
Toolboxes
COVID-19
112
Rapid Response
58
AMR
52
NTDs
38
HIV
20
TB
19
Mental Health
18
Pharmacy
18
Ebola
16
Planetary Health
15
Zika
12
NCDs
9
Cholera
6
Disability
5
Caregiver
5
Specific Hazards
4
Refugee
4
Natural Hazards
3
Conflict
3
Health Financing Toolbox
2
Polio
2
Global Health Education
2
Sub-Saharan African Journal of Medicine: Year : 2014 | Volume : 1 | Issue : 1 | Page : 1-14
Policy
25 February 2015 Vol 7 Issue 276 276fs8
Replacement of Annex 2 of WHO Technical Report Series, No. 964...
Original text from 2008, updated in 2012. This document marks the beginning of a structured approach to safety assessment of GE foods, which are yet to be approved in our country. It is understood that many changes will become necessary and will be incorporated as we progress. This document will ho...
The Georgetown Undergraduate Journal of Health Services (2), 2012.
African Health Sciences 2013; 13(2): 219 - 232 http://dx.doi.org/10.4314/ahs.v13i2.4
Guideline
SAJHIVMED DECEMBER 2013, Vol. 14, No. 4
Int J Health Policy Manag 2017, 6(10), 587–600
Low-income countries face many contextual challenges to manage healthcare technologies effectively, as the majority are imported and resources are constrained to a greater extent. Previous healthcare technology management (HTM) policies in Benin ha...
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections and could potentially
extend the lifespan of current narrow- spectrum antimicrobials. Althoug...
Accessed Febr. 6, 2020
Antimicrobial resistance (AMR) is a major global public health concern and a food safety issue. When pathogens become resistant to antimicrobial agents they can pose a greater human health risk as a result of potential treatment failure, loss of treatment options and increased likelihood and severi...
Protocol and preliminary evaluationas of Jan 17, 2020
Event-based surveillance (EBS) is defined as the organized collection, monitoring, assessment and interpretation of mainly unstructured ad hoc information regarding health events or risks, which may represent an acute risk to health. Both indicator-based and event-based surveillance components serve...
Interium guidance, 25 June 2021Timely and accurate diagnostic testing is an essential tool in preventing and controlling the spread of COVID-19. This document describes recommendations for national testing strategies and the use of PCR and rapid antigen tests in different transmission scenarios of t...
Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
recommended
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv...
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method...
A toolkit for pharmacists.
Emerging data show that medication errors and adverse events cause significant harm to patients’ health and
well-being. It is estimated that the burden of adverse events due to medicines is now comparable to that of
widespread diseases, such as malaria or tuberculosis...
